Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm, Residual × Irinotecan × Clear all

Sponsor

Conditions

Colorectal Neoplasms 76 Colonic Neoplasms 28 Rectal Neoplasms 27 Neoplasms 22 Pancreatic Neoplasms 20 Esophageal Neoplasms 20 Stomach Neoplasms 19 Neoplasm Metastasis 15 Neuroblastoma 12 Glioma 11 Glioblastoma 9 Sarcoma 8 Carcinoma, Non-Small-Cell Lung 8 Brain Neoplasms 8 Adenocarcinoma Of Esophagus 8 Small Cell Lung Carcinoma 7 Rhabdomyosarcoma 7 Sarcoma, Ewing 6 Gliosarcoma 6 Esophageal Squamous Cell Carcinoma 6 Medulloblastoma 5 Lung Neoplasms 5 Central Nervous System Neoplasms 5 Intestinal Neoplasms 4 Gastrointestinal Neoplasms 4 Digestive System Neoplasms 4 Digestive System Diseases 4 Breast Neoplasms 4 Adenocarcinoma 4 Uterine Cervical Neoplasms 3

Interventions

Rituximab 4 blinatumomab 3 Whole-Body Irradiation 2 Lenalidomide 2 Cyclophosphamide 2 Clofarabine 2 treosulfan 1 thymoglobulin 1 sabatolimab 1 peginterferon alfa-2a 1 obinutuzumab 1 midostaurin 1 ixazomib 1 fludarabine phosphate 1 fludarabine 1 eribulin 1 daratumumab 1 acalabrutinib 1 Trastuzumab 1 Tacrolimus 1 Sodium Chloride 1 Peripheral Blood Stem Cell Transplantation 1 Pentostatin 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Magnetic Resonance Imaging 1 Imatinib Mesylate 1 Histamine Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡